STARD13-AS

Across TCGA pan-cancer cohorts, STARD13-AS RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated STARD13-AS data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher STARD13-AS RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated STARD13-AS expression acts as an unfavorable survival marker, although some lineages such as UCS and LUAD show a favorable association.

ACC, UCS, and COAD are the cancer types where STARD13-AS RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.253	0.637	<.001	88	view →
UCS	DFS	Tertile	II,III,IV	0.709	0.315	.006	26	view →
COAD	DFS	Median	II,III,IV	0.699	0.809	.003	24	view →
CHOL	DFS	Median	II,III,IV	0.112	0.542	.015	20	view →
DLBC	OS	Tertile	III,IV	0.172	1.000	.014	18	view →
LUAD	DFS	Quartile	III,IV	0.733	0.265	.004	16	view →
CESC	OS	Median	All	0.744	0.846	.021	16	view →
LUSC	DFS	Median	II,III,IV	0.265	0.484	.003	14	view →
KIRC	OS	Tertile	All	0.707	0.577	.011	14	view →
PCPG	DFS	Median	All	0.982	0.875	.006	12	view →
THCA	DFS	Tertile	All	0.896	0.798	.010	11	view →
BLCA	DFS	Quartile	IV	0.364	0.532	.040	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

STARD13-AS–ACC (DFS)

Open the ACC breakdown →